ReGenesis: Pioneering Longevity and Preventive Medicine in Canada

As Canada stands on the edge of a health revolution, ReGenesis is emerging as a national leader in longevity medicine—a rapidly evolving discipline focused not just on treating disease, but on extending health span, preventing decline, and optimizing vitality through advanced science.

While the world’s medical and wellness communities have begun to embrace the concept of “biological age” and personalized prevention, few have translated it into a coherent, clinically integrated model. ReGenesis is doing just that—becoming Canada’s pioneer in data-driven longevity care.

A Canadian First: Integrating Longevity Into Clinical Practice

Founded with a vision to transform the way Canadians approach aging and prevention, ReGenesis blends precision diagnostics, advanced therapeutics, and lifestyle optimization into a unified model of care.

At the heart of this approach is the belief that health is dynamic—and measurable. By combining comprehensive bloodwork, hormone optimization, body composition analysis, VO₂ Max testing, and state-of-the-art epigenetic and genomic assessments, ReGenesis empowers patients to understand how their bodies are aging at the cellular level.

Through partnerships with TruDiagnostic, Precision Epigenomics, and Insight Imaging, ReGenesis offers clients access to the same high-resolution longevity tools used by leading U.S. and European research centers—now available right here in Canada.

EpiGenesis Diagnostics: Bringing Science Home

To make these advanced tests more accessible to Canadians, EpiGenesis Diagnostics—a sister company of ReGenesis—serves as the exclusive national provider for TruAge and TruHealth testing kits.

Available at www.epigenesis.ca, these tests measure biological age, pace of aging, and organ-specific aging indicators using validated DNA methylation algorithms. The results provide unparalleled insight into how lifestyle, environment, and medical interventions influence one’s long-term health trajectory.

Through EpiGenesis, clinicians and individuals alike can purchase testing kits directly, enabling broader access to epigenetic insight across the country.

Teamwide Commitment to Longevity Science

Unlike many clinics that simply offer longevity testing, every ReGenesis staff member has undergone formal education in the field.

Earlier this year, the entire ReGenesis clinical and administrative team completed a three-day comprehensive longevity workshop led by Medical Director Dr. Lloyd Tapper, NP, PhD, a recognized expert in regenerative medicine and preventive health.

This immersive training covered topics such as:

• The cellular biology of aging

• Hormone and metabolic optimization

• Epigenetic interpretation and intervention

• Longevity biomarkers and clinical applications

The result is a cohesive, knowledgeable team capable of delivering personalized care rooted in science—not speculation.

Partnerships That Power Precision

ReGenesis has built relationships with globally recognized innovators to ensure clients receive the most advanced diagnostic data available:

• TruDiagnostic – the U.S. leader in clinical epigenetic testing, providing DNA methylation-based biological age and pace-of-aging metrics.

• Precision Epigenomics – offering detailed genomic and methylation insights that map individual aging patterns and disease risk.

• Insight Imaging – delivering advanced diagnostic imaging for cardiovascular and metabolic risk stratification.

This multi-modal collaboration allows ReGenesis to combine imaging, biochemistry, and molecular data into one of the most comprehensive longevity assessment programs in Canada.

Longevity Medicine in Action

At ReGenesis, longevity care extends far beyond testing. It involves translating data into actionable, personalized interventions that may include:

• Hormone optimization (BHRT / TRT)

• Peptide and GLP-1 therapy

• Nutraceutical and pharmaceutical protocols

• Functional fitness and metabolic training

• Sleep, nutrition, and stress optimization programs

By combining objective data with targeted strategies, ReGenesis clients can slow biological aging, reduce disease risk, and sustain vitality well into later life.

Canada’s Frontier in Longevity

The emergence of ReGenesis and EpiGenesis marks a significant step forward in Canadian preventive medicine. In a healthcare system historically focused on treatment rather than prevention, this model offers a new paradigm—one where aging itself becomes measurable, modifiable, and medically managed.

As one of Canada’s first comprehensive longevity centers, ReGenesis isn’t just following global trends—it’s defining them.

Conclusion

ReGenesis and EpiGenesis are forging a new path in Canadian health care—one where prevention, diagnostics, and rejuvenation converge to extend both life and vitality.

With cutting-edge partnerships, rigorous staff training, and a data-driven philosophy, these organizations are not just improving how Canadians age—they’re redefining what it means to live well.

Learn more at www.regenesisalberta.com and www.epigenesis.ca.

Bibliography & References

1. TruDiagnostic. Epigenetic Aging and Biological Clocks in Clinical Practice. 2024. Available at https://www.trudiagnostic.com

2. Belsky, D.W. et al. “Quantification of the pace of biological aging in humans through a blood test, the DunedinPACE.” Nature Aging 2, 697–708 (2022).

3. Horvath, S. & Raj, K. “DNA methylation-based biomarkers and the epigenetic clock theory of ageing.” Nature Reviews Genetics 19, 371–384 (2018).

4. Levine, M.E. et al. “An epigenetic biomarker of aging for lifespan and healthspan.” Aging 10(4), 573–591 (2018).

5. Insight Imaging Canada. Advanced Preventive Imaging for Longevity Medicine. 2024.

6. Precision Epigenomics. Clinical Genomic and Epigenomic Testing Portfolio. 2024.

7. Tapper, L. (2024). ReGenesis Longevity Training Manual. Internal Workshop Proceedings, ReGenesis Longevity Clinic, Edmonton.

8. EpiGenesis Diagnostics. TruAge and TruHealth Testing Across Canada. Available at https://www.epigenesis.ca.